Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

alcon laboratories (new zealand) limited - naphazoline hydrochloride 0.1% (0.105% with manufacturers overage.) - eye drops, solution - 0.1 % - active: naphazoline hydrochloride 0.1% (0.105% with manufacturers overage.) excipient: benzalkonium chloride boric acid disodium edetate dihydrate hydrochloric acid potassium chloride purified water sodium carbonate monohydrate sodium chloride - naphcon forte eye drops are indicated for use as a topical ocular vasoconstrictor.

Armenië - Engels - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

laboratories inibsa s.a. - articaine (articaine hydrochloride), epinephrine (epinephrine tartrate) - solution for injection - 40mg/ml+0,01mg/ml

Ierland - Engels - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - tramadol hydrochloride - tablet prolonged release - 100 milligram

Europese Unie - Engels - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - oritavancin (diphosphate) - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, - tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and paediatric patients aged 3 months and older (see sections 4.2, 4.4 and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.

Filipijnen - Engels - FDA (Food And Drug Administration)

alstar chemie sales (philippines) - sodium ascorbate - capsule - 500mg (equivalent to 444.5mg ascorbic acid)

Verenigde Staten - Engels - NLM (National Library of Medicine)

pliva inc. - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - paroxetine hydrochloride - oral tablet - 30mg

Verenigde Staten - Engels - NLM (National Library of Medicine)

teva parenteral medicines, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin's lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

komedic sdn bhd - clavulanic acid; amoxycillin -

Filipijnen - Engels - FDA (Food And Drug Administration)

n/a; importer: n/a; distributor: n/a - salicylic acid , resorcinol - topical solution - 2.5 g/2.5 g per 100ml